Grainne Quinn
Chief Tech/Sci/R&D Officer chez PERRIGO COMPANY PLC
Fortune : 678 501 $ au 31/03/2024
Profil
Actuellement, Grainne Quinn occupe le poste de Chief Medical Officer & Executive Vice President chez Perrigo Co. Plc. Le Dr Quinn a précédemment occupé le poste de Chief Medical Officer chez Elan Corp. Plc. Le Dr Quinn a obtenu un doctorat du Royal College of Surgeons.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
PERRIGO CO. PLC
0,02% | 05/04/2024 | 21 078 ( 0,02% ) | 678 501 $ | 31/03/2024 |
Postes actifs de Grainne Quinn
Sociétés | Poste | Début |
---|---|---|
PERRIGO COMPANY PLC | Chief Tech/Sci/R&D Officer | 01/11/2015 |
Anciens postes connus de Grainne Quinn
Sociétés | Poste | Fin |
---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 01/12/2013 |
Formation de Grainne Quinn
Royal College of Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PERRIGO COMPANY PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |